3 Medicaid coverage for weight-loss drugs Medicaid is required to provide coverage for any FDA-approved drug that meets the federal definition of a covered outpatient drug and for which the manufacturer has entered into a rebate agreement with the Department of Health and Human Services Secretary (i.e., the Medicaid Drug Rebate Program [MDRP])
It also slows down how quickly food leaves your stomach, leading to a prolonged feeling of fullness, which in turn helps reduce overall food intake and promotes weight loss
Additionally, GLP-1 suppresses glucagon secretion from pancreatic alpha cells, slows gastric emptying to moderate the rate at which nutrients enter the bloodstream, and acts on the brain to promote satiety and reduce appetite
Combining GLP-1 analogues with other weight loss medications may enhance results, and researchers continue to study their long-term efficacy and sustainability
It is not supported by any clinical trials
Studies have found that moderate- to high-intensity cardio are best for increasing GLP-1, but regular exercise (even if its low intensity) helps
:max_bytes(150000):strip_icc()/WhatstheDifferenceBetweenOzempicWegovyandMounjaro-illo-a8f5a23fe4914586b4488472fe15f112.png)
